These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 9307285

  • 1. An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy.
    Henderson BW, Bellnier DA, Greco WR, Sharma A, Pandey RK, Vaughan LA, Weishaupt KR, Dougherty TJ.
    Cancer Res; 1997 Sep 15; 57(18):4000-7. PubMed ID: 9307285
    [Abstract] [Full Text] [Related]

  • 2. Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapy.
    Potter WR, Henderson BW, Bellnier DA, Pandey RK, Vaughan LA, Weishaupt KR, Dougherty TJ.
    Photochem Photobiol; 1999 Nov 15; 70(5):781-8. PubMed ID: 10568170
    [Abstract] [Full Text] [Related]

  • 3. Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide-a derivatives.
    MacDonald IJ, Morgan J, Bellnier DA, Paszkiewicz GM, Whitaker JE, Litchfield DJ, Dougherty TJ.
    Photochem Photobiol; 1999 Nov 15; 70(5):789-97. PubMed ID: 10568171
    [Abstract] [Full Text] [Related]

  • 4. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giercksky KE, Nesland JM.
    Cancer Res; 2001 Aug 01; 61(15):5824-32. PubMed ID: 11479222
    [Abstract] [Full Text] [Related]

  • 5. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy.
    Li G, Slansky A, Dobhal MP, Goswami LN, Graham A, Chen Y, Kanter P, Alberico RA, Spernyak J, Morgan J, Mazurchuk R, Oseroff A, Grossman Z, Pandey RK.
    Bioconjug Chem; 2005 Aug 01; 16(1):32-42. PubMed ID: 15656573
    [Abstract] [Full Text] [Related]

  • 6. Comparative in vitro and in vivo studies on long-wavelength photosensitizers derived from bacteriopurpurinimide and Bacteriochlorin p6: fused imide ring enhances the in vivo PDT efficacy.
    Chen Y, Potter WR, Missert JR, Morgan J, Pandey RK.
    Bioconjug Chem; 2007 Aug 01; 18(5):1460-73. PubMed ID: 17705415
    [Abstract] [Full Text] [Related]

  • 7. Photosensitizers derived from 132-oxo-methyl pyropheophorbide-a: enhanced effect of indium(III) as a central metal in in vitro and in vivo photosensitizing efficacy.
    Rosenfeld A, Morgan J, Goswami LN, Ohulchanskyy T, Zheng X, Prasad PN, Oseroff A, Pandey RK.
    Photochem Photobiol; 2006 Aug 01; 82(3):626-34. PubMed ID: 16277564
    [Abstract] [Full Text] [Related]

  • 8. Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible "see and treat" approach.
    Pandey SK, Gryshuk AL, Sajjad M, Zheng X, Chen Y, Abouzeid MM, Morgan J, Charamisinau I, Nabi HA, Oseroff A, Pandey RK.
    J Med Chem; 2005 Oct 06; 48(20):6286-95. PubMed ID: 16190755
    [Abstract] [Full Text] [Related]

  • 9. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
    Bellnier DA, Greco WR, Loewen GM, Nava H, Oseroff AR, Pandey RK, Tsuchida T, Dougherty TJ.
    Cancer Res; 2003 Apr 15; 63(8):1806-13. PubMed ID: 12702566
    [Abstract] [Full Text] [Related]

  • 10. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.
    Brasseur N, Ouellet R, La Madeleine C, van Lier JE.
    Br J Cancer; 1999 Jul 15; 80(10):1533-41. PubMed ID: 10408394
    [Abstract] [Full Text] [Related]

  • 11. Structure-activity relationships of mono-substituted trisulfonated porphyrazines for the photodynamic therapy (PDT) of cancer.
    Cauchon N, Ali H, Hasséssian HM, van Lier JE.
    Photochem Photobiol Sci; 2010 Mar 15; 9(3):331-41. PubMed ID: 20221459
    [Abstract] [Full Text] [Related]

  • 12. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA, Gollnick SO, Camacho SH, Greco WR, Cheney RT.
    Cancer Res; 2003 Nov 15; 63(22):7584-90. PubMed ID: 14633671
    [Abstract] [Full Text] [Related]

  • 13. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
    Seshadri M, Spernyak JA, Mazurchuk R, Camacho SH, Oseroff AR, Cheney RT, Bellnier DA.
    Clin Cancer Res; 2005 Jun 01; 11(11):4241-50. PubMed ID: 15930363
    [Abstract] [Full Text] [Related]

  • 14. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V, Grazeliene G, Dabkeviciene D, Micke I, Kirvelis D, Juodka B, Didziapetriene J.
    Cancer Chemother Pharmacol; 2006 Jan 01; 57(1):65-72. PubMed ID: 16001168
    [Abstract] [Full Text] [Related]

  • 15. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
    Maugain E, Sasnouski S, Zorin V, Merlin JL, Guillemin F, Bezdetnaya L.
    Oncol Rep; 2004 Sep 01; 12(3):639-45. PubMed ID: 15289849
    [Abstract] [Full Text] [Related]

  • 16. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent.
    Henderson BW, Sitnik-Busch TM, Vaughan LA.
    Photochem Photobiol; 1999 Jul 01; 70(1):64-71. PubMed ID: 10420844
    [Abstract] [Full Text] [Related]

  • 17. Structure-activity relationship among purpurinimides and bacteriopurpurinimides: trifluoromethyl substituent enhanced the photosensitizing efficacy.
    Gryshuk A, Chen Y, Goswami LN, Pandey S, Missert JR, Ohulchanskyy T, Potter W, Prasad PN, Oseroff A, Pandey RK.
    J Med Chem; 2007 Apr 19; 50(8):1754-67. PubMed ID: 17371002
    [Abstract] [Full Text] [Related]

  • 18. Comparison between 5,10,15,20-tetraaryl- and 5,15-diarylporphyrins as photosensitizers: synthesis, photodynamic activity, and quantitative structure-activity relationship modeling.
    Banfi S, Caruso E, Buccafurni L, Murano R, Monti E, Gariboldi M, Papa E, Gramatica P.
    J Med Chem; 2006 Jun 01; 49(11):3293-304. PubMed ID: 16722648
    [Abstract] [Full Text] [Related]

  • 19. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
    Triesscheijn M, Ruevekamp M, Aalders M, Baas P, Stewart FA.
    Photochem Photobiol; 2005 Jun 01; 81(5):1161-7. PubMed ID: 15934792
    [Abstract] [Full Text] [Related]

  • 20. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
    Engbrecht BW, Menon C, Kachur AV, Hahn SM, Fraker DL.
    Cancer Res; 1999 Sep 01; 59(17):4334-42. PubMed ID: 10485481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.